The protein pättern of cerebrospinal fluid (CSF) of 334 patients with various neurological and systemic diseases was investigated by high resolution two-dimensional electrophoresis (2-DE). 2-DE gels of normal CSF contain piroteins which are not detectable in 2-DE gels of serum. Disturbances of the bloodbrain or blood^CSF barrier, and degenerative diseases of the brain and malignant diseases produce specific changes on 2-DE gels of the CSF. The appearance of 10 spot areas in the light chain region of 2-DE gels seem to be connected with the diagnosis of multiple sclerosis. The sensitivity and the specificity of these spot areas for the diagnosis of multiple jsclerosis are described. Proteins within the ten spot areas are immunoglobulin light chains or sübstances which cross-react very strongly with light chain antibodies äs demonstrated by immunoblottiiig and iIilm^nöäbso tion.
Endlcr et al.: 2 D-eleotrophorcsis of cercbrospinal fluid in patients with neurological disoases markedly affect the protein pattern of the CSR Such changes, c.g. multiple sclerosis (1) or disorders of the blood-brain barrier (10) are used diagnostically. Malignant and infectious diseases may also alter CSF protein concentrations and patterns.
High resolution 2-DE in polyacrylamide gels (PAGE), äs described originally by O'Farrell (11) and later adapted for serum by Anderson & Anderson (12) , is a very powerfull technique for resolving proteins in biological fluids, particularly when it is combined with a silver staining procedure (13) . This method has been adapted for CSF by Merril et al. (14) and we have used a modification of the Anderson procedure (1).
Materials and Methods

Patients and cerebrospinal fluid
Three hundred and thirty four CSF specimens were collected from patients from, 3 to 87 years of age who underwent diagnostic spinal taps and spinal myelograms at the Mayo Clinic. Approximately equal numbers of the sexes were represented. CSF specimens were received in the laboratory within one hour after spinal tap. Specimens were centrifuged to remove cellular elements and stored at -70 °C until analysed by 2-DE.
Clinical analysis and the laboratory procedure were carried out independently.
Sixteen patients who had no evidence of any organic neurological or systemic diseases such äs vascular or tension headache, idiopathic scoliosis, tension myalgia, or atypical facial pain, were used äs the control group. Other patients were divided into 13 disease groups (tab. 1). The second dimension, SDS-PAGE in a 100 g/l to 230 g/l acrylamide gradient slab gel, was performed in DALT tanks (Electro/Nucleonics, Inc., Oak Ridge, TN, USA) with a buffer containing 3.5 mmol/1 SDS, 24 mmol/1 tris, 0.2 mol/1 glycine.
2-DE gels were stained with ammoniacal silver nitrate and formaldehyde citrate (15, 16) . Stained 2-DE gels were photographed and inspected and evalüated visually. Spots on the 2-DE gels of CSF were identified by comparison with a reference map of normal human serum (15) . The reproducibility of 2-DE has been described previously (15) .
Specimen preparation
Specimens containing 300 § of protein (deterrained turbidimetrically on the aca III (Du Pont, Inc., Wilmington, DE, USA) were dialysed against 0.1 mol/1 ammonium formate and concentrated by lyophilization. In prelirainary experiments we found that with this procedure at least 96% of the starting protein quantity was recovered. Protein was dissociated by heating for 5 min at 95 °C in 100 sample preparation buffer, pH 9.5, containing 20 g/l sodium dodecylsulphate (SDS), 50 g/l mercaptoethanol, 50 mmol/1 cyclohexylamino sulphonic acid (CHES, Calbiochem, San Diego, CA, USA), and 100 g/l glycerol. Ten samples of this preparation were loaded in duplicate on ISOgels. Electrophoresis 2-DE was performed by a modification of the 1SO-DALT System of Anderson & Anderson (12) äs described previously (2, 15) . The ßrst or ISO-dimension is isoelectric focusing in polyacrylamide (35 g/l) under denaturing conditions: 9mol urea, 20 g surfactant NP-40, 19 g 3.5-10 ampholytes, and 5 g 5-7 ampholytes (Ampholines, LKB Instruments, Rockville, MD, USA), 1.6g arginine and 1.0g lysine were added to 11 of acrylamide solution. Isoelectric focusing was performed.at 10600 Vh after prefocusing for l h at 200V with 0.85 g/l phosphoric acid äs anolyte and 1.0 mol/1 sodium hydroxide äs catholyte. ISO-gels were equilibrated subsequently in a buffer containing 20 g/l SDS for 8 min and quickly frozen in a solid CO 2 /ethanol bath.
Immunoabsorption
Antibodies against the human kappa and lambda light chains (Dakopatts, Accurate Chemical & Scientific Corporation, Westbury, NY, USA) were coupled to CNBr-activated Sepharose 4B (Pharmacia, Piscataway, NJ, USA) following the procedure described by the manufacturer and Dermer et äl. (4) . Antibody protein (2 mg) was coupled to l ml gel at 4 °C and incubated overnight in a buffer at pH 8.3 containing 0.1 mol/1 sodium bicarbonate and 0.5 mol/1 sodium chloride. Free ligands were blocked with l mol/1 ethanolamine at pH 8.0 and excess protein was washed off with 0.1 mol/1 aeetate buffer containing 0.5 mol/1 sodium chloride and 2 g/l detergent Tween 20. Antibö-dy-coupled Sepharose was equilibrated and stored in phosphate-buffered saline pH 7.2 with 10 mg/1 sodium azide.
Immunoabsorption was performed in microcolumns (3 ml disposable syringes) filled with l ml Sepharose coupled to the individual antibody. Three CSF and three human serum specimens, each containing 350 g protein were first absorbed on the anti-kappa antibody colurrm, and in a second Step the eluent was absorbed on the anti-lambda antibody colümn. The specimen, from which light chains had been depleted, was treated in the same way äs the original CSF specimen (foliowing dialysis and lyophilization) and subjected to 2-DE. Bound light chains were eluted in two steps; first with an acid glycine bufier (0.1 mol/1 glyeine and 0.5 mol/1 sodium chloride adjusted to pH 2.5 with 0.2 mol/1 hydrochloric acid), then elution was repeated with 100 ml/l dioxane in the same buffer. The pH of the eluate was immediately raised by addition of solid tris. The eluate was treated in the same way äs the absorbed samples. (17) . The transfer bufier consisted of 25 ramol/1 tris, 192 mmol/1 glycine and 200 ml/l melhanoi at pH 8.3. The blotting was performed at 150 V for 3 h with cooling; nitrocelhilose sheets were removed from the SDS-polyacrylamide gel and blocked in 30 g/l gelatin for l h in tris-buffered saline at pH 7.5 (20 mmol/1 tris and 0.5 mol/1 sodiura Chloride). Then the sheets were incubated for 90 min in a first antibody solution at a concentration of l: 500. Antibodies were raised in rabbits (Dakopatts, Accurate Chemical & Scientific Corporation, Westbury, NY, USA). After washing the nitrocellulose sheets in tris-buffered saline (four times for 20 min at room temperature), they were incubated with a second anli-rabbit antibody coupled with horseradish peroxidase (Bio-Rad Laboratories, Richmond, CA, USA) at a concentration of l : 1500. Again the sheets were washed extensively in tris-buffered saline, and specific proteins were visualized by addition of 4-chloro-naphthol and hydrogen peroxide.
between these spots and any diseases, but the proteins in this area seem to be more prominent in inflammatory states. The light chains in CSF differ from those in serum äs exemplified by spots 12-17 in figure 1 . The difference in spot 15 is characteristic for 2-DE gels of CSF and is not apparent in other biological fhiids (amniotic fluid, urine, saliva, pleural and abdominal effusions) that we have studied.
The relative amount of transthyretin (area 11 in fig.  1 ) is increased in CSF compared with serum. The cathodic end of transferrin (area 4 in fig. 1 ) is more basic in CSF than in serum. Also, the heavy chains of IgG (gamma chains in fig. 1 ) in CSF differ from those iri serum with the basic end of the chain being less pronounced. The electrical charges of the gamma heavy chain subunits are somewhat different.
Results
The most obvious differences between 2-DE gels of proteins from serum and CSF are apparent in 4 ) typically have well defined edges. For spots in these areas the signs + -h, and +, refer to the amount of protein. The combined frequency of and + + spots from CSF of patients wiih multiple sclerosis and other demyelinating diseases was significantly different (p < 0.01) from CSF from patients withöüt clinical evidence of demyelinating diseases. We also calculated the specificity and seasitivity öf each spot for multiple sclerosis (18) . One value was calculated for sensitivity and specificity fqr spot areas classified with both and + + and another value for spots classified with both and + + together with and +. The true positive rates (sensitivity) were plotted against the false positive rates (l -specificity), and receiver operating characteristic (RÖC) curves were drawn (fig, 5) . The detection of a protein within spot areas with + and + -l-and and reveals a high ated spots could not cleafly be determined by this method. Therefore we took CSF specimens from other patients with the same diagnosis, and depleted the imimmoglobulin light chains (kappa and lambda) by immunoabsorption. One CSF specimen of a patient with multiple sclerosis was absorbed twice before analysis by 2-DE. Spots 2, 3, and 4 in figure  4 largely disappeared with absorption, although they were still faintly visible, while the spots l, 5, 6, 7, 8, 9, and 10 of figure 4 disappeared completely. Nevertheless, the strong reaction suggests that the multiple sclerosis-associated proteins in the light chain region are immunoglobulin light chains themselves or proteins which show a very high cross-reactivity with immunoglobulin light chains.
Laboratory data concerning the CSF IgG index (ratio of IgG and albumin in CSF divided by the ratio of IgG and albumin in serum) and the presence of oligoclonal bands (determined by agarose gel electrophoresis) were available in only a few cäses. Whenever the CSF IgG index was increased or oligoclonal bands were present, the spots associated with multiple sclerosis were observed on 2-DE gels of CSF within the light chain area. There was no v ' single spot area f that was characteristic of a high index or presence of oligoclonal bands, and several patients demonstrated multiple sclerosis-associated spots, although their CSF IgG index was in the reference ränge and no oligoclonal bands were present. A protein Spot described äs specific for Parkinsorfs disease by Harrington & Menü (7) was also found in all three patients with this disease whom we investigated ( fig. 4F) . However, the same spot was also in the CSF of about one half of the patients with Alzheimer's disease and other dementias and, to a much lesser extent, in CSF specimens from patients with other diseases (fig. 4 E) .
Discussion
As our normal control population, we selected CSFs from patients who showed no evidence of any neurological or systemic disease, and established a reference map for 2-DE gels of CSF which has been published previously (2) . This map shows several additional proteins not present in the map of CSF from normal individuals published by Goldman et al. (5) . However, it is uncertain whether these differences are related to the use of different silver stains or to different control populations. The protein concentration of CSF is about one twohundredth of that in serum. We always loaded ISOgels with the same amount of protein to facilitate Interpretation of gel patterns. The protein concentrations in the CSF specimens varied from 18 mg/1 to more than 100 mg/1. Therefore different volumes of CSF were subjected to 2-DE. Upon comparing 2-DE gels from serum and from concentrated CSF containing the same amount of protein, we identified several spots which are present in CSF only. This does not mean that they are not derived from serum, because they could be present at a concentration below the threshold of detection.
Comparison of 2-DE gels of serum and CSF shows that proteins in spot area 8 ( fig. 1 ) are present in concentrated CSF but not in serum, but no relationship could be established with any disease state. We suspect that this group of spots is associated with inflammatory states affecting the CNS. Spots of area 8 ( fig. 1 ) are similar in appearance to apolipoproteins on 2-DE gels stained with silver nitrate with the method described by Oakly (16) and the area overlaps apolipoprotein E in 2-DE gels of serum (15) . This area consists of at least three different proteins (19) .
Spots of area 10 in figure l have been described äs specific for CSF (6) . However, we have observed these spots in 2-DE gels of pleural and abdominal effusions and in sera which have been stored over several years in a freezer with multiple freeze-thawings (personal observation). The spots may therefore be related to degradation of larger proteins. Their presence in CSF may indicate either enhanced degradation of proteins in CSF or slow metabolic elimination of degraded proteins from the CSF. Additionally these spots reacted with antibocfies against light chains which suggests an antigenic relationship with these immunoglobulin subuinits.
Transthyretin (spot 11 in fig. 1 ), which appears to contain more aeidic subunits in CSF than in serum (6) , is present normally at a higher concentration in CSF than in serum. When the serum traüsthyretin is increased, additional aeidic subunits show up on 2-DE gels (15) . Andersen & Anderson have demonstrated micro-r heterogeneity of transferrin in serum due tö neürami-nidase digestible residues (21) . The anodic end of transferrin, which is much more pronounced in CSF than in serum, may be due to a diminished amount of neuraminidase digestible residues since, treatment of serum with neuraminidase produced a siinilar transferrin pattern on their 2-DE gels. A conversion of iron-1 -transferrin to apo-transferrin might also be a reason for the more basic appearance of transferrin on 2-DE gels of CSF when compared with 2-DE gels of serum. The relative increase of some serum proteins in CSF in patients with a damaged blood-brain or blood-CSF barrier suggests that quantitative analysis of these protein spots might produce further Information on the degree of damage. Thus the absolute amount of protein together with the molecular size and Charge of specific proteins might be of value in assessing the extent of damage.
The spots we have found in CSF of patients with malignancies involving the CNS were not constant from patient to patient, except for a series of spots which we found in three patients with acute lymphatic leukaemia. Each of these spots must be characterized, and investigated in other patients with leukaemia and other diseases to establish its diagnostic specificity.
Certain imimmoglobulins have been described äs oligoclonal bands in CSF of patients with multiple sclerosis. They also appear in other inflammatory processes of the CNS which are usually accompanied by increased immunoglobulin concentrations in the CSF. Oligoclonal bands in CSF äre not specific for multiple sclerosis (1) . Changes in the light chain area and particularly the formation of additional spots have been noted with 2-DE previously (2, 3, 8, 21) . The density of these areas correlated well with oligoclonal band formation (3, 8) .
In this study we decided to characterize spots which seemed to be associated with multiple sclerosis according to their sharp edge and clearly distinguishable nature ( fig. 4, The diagnostic relevance of the light chain area on 2-DE gels from CSF of patients with multiple sclerosis is of interest. Harrington et al. (8) described certain areas äs multiple sclerosis-related, and these appear to be the same äs our multiple sclerosisassociated areas. Their spot area 118 seems to be identical to our spot area 2 ( fig. 4) , their spot area 119 with our spot area 3, their spot area 115 with our spot area 4, and their spot area 114 with our spot area 5. The more basic light chain spots in our gels are outside the ränge of these investigators' isoelectric protein Separation. By adding basic amino acids and a highly concentrated catholyte we achieved better resolution on the basic side of the gel (15) . Additionally, differences in the technique, reagents and patient selection may give rise to the differences between their pattern and ours. It is possible that additionäl spots might be found in the basic end of the light chain region using a different isoelectric gradierit for the first dimension. Harrington et al. (8) describe ari increased density in different areas, while we found spot formations not only in these areas but also in öther areas. Multiple sclerosis is a diagnosis which is mainly established by clinical characteristics. Biochemical parameters such äs CSF IgG concentration, CSF IgG index, or oligoclönal banding do not necessarily concur with the clinical diagnosis of multiple sclerosis (1) . Some patients in the myelopathy group probably have multiple sclerosis. The spots were found in the same area in 2-DE gels of CSF of patients with meningoencephalitis, but were not usually in a configuration typical for multiple sclerosis (fig. 4) . We classified them äs + +, because differentiation is difficult.
The variability of the light chain patterns in 2-DE gels of patients with multiple sclerosis might indicate biochemical and immunological variations connected with this disease. The presence of these spots suggests that patients with multiple sclerosis may form some type of atypical immunoglobulins. Many theories exist about the pathogenesis of multiple sclerosis, including direct and indirect virus effects, autoimmune processes, and deficiencies of the immunoregulatory System (22) . The association of the formation of all or some of these multiple sclerosis-associated spots with a pathogenic agent such äs a virus or autoantigen, or with disturbance of the immunoregulatory System remains to be investigated. The statistical evaluation and the ROC curves show that some of these spots have a high specificity for multiple sclerosis, but a low sensitivity. The evaluation of the presence of protein in the spot areas is highly sensitive for multiple sclerosis, but may not be adequate for the diagnosis of multiple sclerosis, because high specificity is also required (23) .
